News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
644,042 Results
Type
Article (32075)
Company Profile (640)
Press Release (611327)
Multimedia
Podcasts (53)
Webinars (11)
Section
Business (196321)
Career Advice (2101)
Deals (36094)
Drug Delivery (102)
Drug Development (77422)
Employer Resources (163)
FDA (15125)
Job Trends (14601)
News (330626)
Policy (28509)
Tag
Academia (1244)
Academic (1)
Accelerated approval (5)
Adcomms (13)
Allergies (84)
Alliances (46639)
ALS (94)
Alzheimer's disease (1298)
Antibody-drug conjugate (ADC) (137)
Approvals (15115)
Artificial intelligence (245)
Autoimmune disease (28)
Automation (13)
Bankruptcy (375)
Best Places to Work (10826)
BIOSECURE Act (22)
Biosimilars (97)
Biotechnology (437)
Bladder cancer (76)
Brain cancer (24)
Breast cancer (245)
Cancer (2092)
Cardiovascular disease (166)
Career advice (1733)
Career pathing (32)
CAR-T (148)
Cell therapy (426)
Cervical cancer (17)
Clinical research (63518)
Collaboration (838)
Compensation (522)
Complete response letters (27)
COVID-19 (2173)
CRISPR (42)
C-suite (258)
Cystic fibrosis (98)
Data (2095)
Decentralized trials (2)
Denatured (3)
Depression (49)
Diabetes (250)
Diagnostics (6297)
Digital health (17)
Diversity (3)
Diversity, equity & inclusion (37)
Drug discovery (112)
Drug pricing (101)
Drug shortages (24)
Duchenne muscular dystrophy (88)
Earnings (82891)
Editorial (37)
Employer branding (24)
Employer resources (139)
Events (109082)
Executive appointments (742)
FDA (16284)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (733)
Gene editing (109)
Generative AI (24)
Gene therapy (302)
GLP-1 (715)
Government (2846)
Grass and pollen (6)
Guidances (51)
Healthcare (15806)
Huntington's disease (23)
IgA nephropathy (29)
Immunology and inflammation (127)
Indications (29)
Infectious disease (2308)
Inflammatory bowel disease (133)
Inflation Reduction Act (8)
Influenza (49)
Intellectual property (97)
Interviews (424)
IPO (17183)
IRA (41)
Job creations (4203)
Job search strategy (1436)
Kidney cancer (10)
Labor market (36)
Layoffs (538)
Leadership (19)
Legal (7090)
Liver cancer (70)
Lung cancer (296)
Lymphoma (136)
Machine learning (4)
Management (58)
Manufacturing (321)
MASH (66)
Medical device (13483)
Medtech (13488)
Mergers & acquisitions (19458)
Metabolic disorders (666)
Multiple sclerosis (81)
NASH (18)
Neurodegenerative disease (98)
Neuropsychiatric disorders (31)
Neuroscience (1846)
NextGen: Class of 2025 (5939)
Non-profit (1869)
Now hiring (40)
Obesity (359)
Opinion (247)
Ovarian cancer (69)
Pain (89)
Pancreatic cancer (80)
Parkinson's disease (146)
Partnered (19)
Patents (237)
Patient recruitment (108)
Peanut (48)
People (56542)
Pharmaceutical (132)
Pharmacy benefit managers (16)
Phase I (20018)
Phase II (28414)
Phase III (21005)
Pipeline (1190)
Policy (135)
Postmarket research (1895)
Preclinical (8053)
Press Release (64)
Prostate cancer (103)
Psychedelics (35)
Radiopharmaceuticals (260)
Rare diseases (374)
Real estate (5678)
Recruiting (64)
Regulatory (20485)
Reports (35)
Research institute (1278)
Resumes & cover letters (330)
Rett syndrome (4)
RNA editing (5)
RSV (43)
Schizophrenia (76)
Series A (135)
Series B (90)
Service/supplier (26)
Sickle cell disease (51)
Special edition (16)
Spinal muscular atrophy (145)
Sponsored (21)
Startups (3869)
State (2)
Stomach cancer (12)
Supply chain (70)
Tariffs (42)
The Weekly (49)
Vaccines (648)
Venture capitalists (44)
Weight loss (243)
Women's health (24)
Worklife (19)
Date
Today (173)
Last 7 days (866)
Last 30 days (2623)
Last 365 days (32959)
2025 (10599)
2024 (35464)
2023 (40205)
2022 (50321)
2021 (53457)
2020 (50478)
2019 (41664)
2018 (31851)
2017 (32294)
2016 (30391)
2015 (35796)
2014 (28461)
2013 (23447)
2012 (25033)
2011 (25205)
2010 (23087)
Location
Africa (662)
Alabama (59)
Alaska (6)
Arizona (159)
Arkansas (11)
Asia (39771)
Australia (6483)
California (6154)
Canada (1990)
China (526)
Colorado (265)
Connecticut (278)
Delaware (140)
Europe (86682)
Florida (860)
Georgia (203)
Hawaii (1)
Idaho (55)
Illinois (458)
India (28)
Indiana (316)
Iowa (12)
Japan (155)
Kansas (99)
Kentucky (23)
Louisiana (11)
Maine (65)
Maryland (752)
Massachusetts (4741)
Michigan (233)
Minnesota (393)
Mississippi (2)
Missouri (82)
Montana (30)
Nebraska (22)
Nevada (58)
New Hampshire (66)
New Jersey (1731)
New Mexico (30)
New York (1705)
North Carolina (1054)
North Dakota (7)
Northern California (2668)
Ohio (186)
Oklahoma (10)
Oregon (40)
Pennsylvania (1337)
Puerto Rico (12)
Rhode Island (35)
South America (1051)
South Carolina (21)
South Dakota (1)
Southern California (2241)
Tennessee (82)
Texas (889)
United States (22909)
Utah (176)
Virginia (143)
Washington D.C. (57)
Washington State (570)
West Virginia (3)
Wisconsin (51)
644,042 Results for "patterson companies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Patterson Companies Reports Fiscal 2024 Third Quarter Operating Results
Patterson Companies, Inc. reported operating results for its fiscal 2024 third quarter ended January 27, 2024.
February 28, 2024
·
24 min read
Press Releases
Metrion Biosciences appoints Lee Patterson as CEO
November 25, 2024
·
2 min read
Business
Patterson Companies Fiscal 2024 Third Quarter Conference Call Scheduled for Wednesday, February 28, 2024
Patterson Companies announced that it will hold its fiscal 2024 third-quarter call on Wednesday, February 28, 2024, at 7:30 a.m. CT.
February 21, 2024
·
1 min read
Press Releases
Zymeworks Appoints Leone Patterson as Chief Business and Financial Officer
July 26, 2024
·
7 min read
Business
Oxford Biomedica Appoints Leone Patterson as Non-Executive Director
Oxford Biomedica plc (LSE:OXB) today announces the appointment of Ms Leone Patterson as an Independent Non-Executive Director.
April 26, 2023
·
3 min read
Job Trends
9 Companies Hiring in Massachusetts
Looking for a biopharma job in Massachusetts? Check out the
BioSpace
list of nine companies hiring life sciences professionals like you.
April 17, 2025
·
2 min read
·
Angela Gabriel
Career Advice
The Top 12 Companies Hiring in Biopharma Now
Looking for a biopharma job? Check out the
BioSpace
list of 12 top companies hiring life sciences professionals like you.
May 1, 2025
·
1 min read
·
Angela Gabriel
Job Trends
7 Companies Hiring in Indiana
Looking for a biopharma job in Indiana? Check out the
BioSpace
list of seven companies hiring life sciences professionals like you.
March 27, 2025
·
1 min read
·
Angela Gabriel
Opinion
Companies Vie to Develop a Hunter Syndrome Therapy That Reaches the Brain
Several companies—including JCR Pharmaceuticals, Denali Therapeutics and Regenxbio—have products in the pipeline that could improve treatment options for this rare disease.
February 3, 2025
·
3 min read
·
Jia Jie Chen
Business
Patterson Companies Fiscal 2022 Second-Quarter Conference Call Scheduled for Wednesday, December 1, 2021
Patterson Companies announced that it will hold its fiscal 2022 second-quarter conference call on Wednesday, December 1, 2021 at 7:30 a.m. CT.
November 23, 2021
·
1 min read
1 of 64,405
Next
